دورية أكاديمية

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases

التفاصيل البيبلوغرافية
العنوان: Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
المؤلفون: Giovanna Petrucci, Alessandro Rizzi, Duaa Hatem, Giulia Tosti, Bianca Rocca, Dario Pitocco
المصدر: Antioxidants, Vol 11, Iss 7, p 1408 (2022)
بيانات النشر: MDPI AG, 2022.
سنة النشر: 2022
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: reactive oxygen species, oxidative stress, atherosclerosis, cardiovascular diseases, platelets, scavengers, Therapeutics. Pharmacology, RM1-950
الوصف: Oxidative stress is generated by the imbalance between reactive oxygen species (ROS) formation and antioxidant scavenger system’s activity. Increased ROS, such as superoxide anion, hydrogen peroxide, hydroxyl radical and peroxynitrite, likely contribute to the development and complications of atherosclerotic cardiovascular diseases (ASCVD). In genetically modified mouse models of atherosclerosis, the overexpression of ROS-generating enzymes and uncontrolled ROS formation appear to be associated with accelerated atherosclerosis. Conversely, the overexpression of ROS scavenger systems reduces or stabilizes atherosclerotic lesions, depending on the genetic background of the mouse model. In humans, higher levels of circulating biomarkers derived from the oxidation of lipids (8-epi-prostaglandin F2α, and malondialdehyde), as well as proteins (oxidized low-density lipoprotein, nitrotyrosine, protein carbonyls, advanced glycation end-products), are increased in conditions of high cardiovascular risk or overt ASCVD, and some oxidation biomarkers have been reported as independent predictors of ASCVD in large observational cohorts. In animal models, antioxidant supplementation with melatonin, resveratrol, Vitamin E, stevioside, acacetin and n-polyunsaturated fatty acids reduced ROS and attenuated atherosclerotic lesions. However, in humans, evidence from large, placebo-controlled, randomized trials or prospective studies failed to show any athero-protective effect of antioxidant supplementation with different compounds in different CV settings. However, the chronic consumption of diets known to be rich in antioxidant compounds (e.g., Mediterranean and high-fish diet), has shown to reduce ASCVD over decades. Future studies are needed to fill the gap between the data and targets derived from studies in animals and their pathogenetic and therapeutic significance in human ASCVD.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2076-3921
Relation: https://www.mdpi.com/2076-3921/11/7/1408; https://doaj.org/toc/2076-3921
DOI: 10.3390/antiox11071408
URL الوصول: https://doaj.org/article/df24575611d54f37acb265350d8ef9d0
رقم الأكسشن: edsdoj.f24575611d54f37acb265350d8ef9d0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20763921
DOI:10.3390/antiox11071408